Last reviewed · How we verify
NCT04517955
TAVI in Intermediate Risk Septuagenarians With Risk Factors Not Captured by the Traditional Surgical Risk Scores
trial testing Transcatheter Aortic Valve Implantation (TAVI) in Transcatheter Aortic Valve Replacement in 80 participants. Status unknown.
1 September 2022
Quick facts
| Lead sponsor | University of Athens |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 80 |
| Start date | 1 July 2020 |
| Primary completion | 1 September 2022 |
| Estimated completion | 30 March 2025 |
| Sites | 5 locations across Greece |
Drugs / interventions tested
- Transcatheter Aortic Valve Implantation (TAVI)
Conditions studied
- Transcatheter Aortic Valve Replacement — all drugs for Transcatheter Aortic Valve Replacement →
Sponsor
University of Athens
Who can join
18 and older, any sex, with Transcatheter Aortic Valve Replacement. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Single arm, observational trial of Transcatheter Aortic Valve Implantation (TAVI) with the Medtronic Evolut R and Evolut Pro The primary objective of this trial is to evaluate device success of TAVI with the Evolut R and Evolut Pro systems in septuagenarians with risk factors for adverse surgical outcomes not captured by the traditional risk scores and therefore of intermediate surgical risk.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04517955
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Transcatheter Aortic Valve Implantation (TAVI)
Trials testing the same drug.
- NCT07179302 — Pre- and Post-TAVI Patient Assessment: Advancing Outcome Precision in Aortic Valve Therapy · completed
- NCT05672823 — Upper Extremity Versus Lower Extremity Accessory Access Sites During Transcatheter Aortic Valve Implantation · NA · completed
- NCT05464472 — Impact of Transcatheter Aortic Valve Implantation (TAVI) on Cognitive Functions · unknown
- NCT04860752 — SAPIEN 3 Ultra EU PMS · completed
- NCT03846557 — PRospective Evaluation Complementing Investigation With Acurate Neo Device · completed
Other recruiting trials for Transcatheter Aortic Valve Replacement
Currently open trials in the same condition.
- NCT06559332 — Coronary Artery Disease Assessment Strategies in TAVI Patients · NA · recruiting
- NCT06896227 — TAVR: The Impact of Prothesis Positioning on Valvular and Coronary Hemodynamics · NA · recruiting
- NCT06420830 — Valve Performance of the SAPIEN 3 Ultra RESILIA Valve: A Prospective Registry With Central Echocardiography Analysis. · recruiting
- NCT05758701 — CT TAVR Abdomen Study · Phase 4 · recruiting
- NCT06000943 — Ischemic And Bleeding Risk Assessment After TAVR · recruiting
Other University of Athens trials
Trials by the same sponsor.
- NCT07469943 — The Effect of Sodium Glucose Co-trnasportert Type 2 Inhibitors on Arterial Stiffness, Endothelial Glycocalyx Thickness a · recruiting
- NCT07254819 — Cotinus Coggygria Mouthwash and Halitosis and Oral Hygiene in Orthodontic Patients · NA · completed
- NCT07069010 — Burnout Syndrome in the Intensive Care Unit Before and During a Palliative Care Trial · recruiting
- NCT06766097 — Chios Mastic Toothpaste and Halitosis and Oral Hygiene in Orthodontic Patients · NA · not yet recruiting
- NCT06885970 — The Effect of Cytisine Treatment for Smoking Cessation on Cardiovascular Function in Adult Smokers · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04517955 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Athens
- Last refreshed: 19 August 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04517955.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing